Dimitris Kadis
Chief Executive Officer at Pharmathen SA
Profile
Dimitris Kadis is currently the Group Chief Executive Officer at Pharmathen SA. He is also the Chief Executive Officer at Pharmathen Global BV.
In addition, he holds the position of Director & Vice President-Corporate Development at Pharmathen Pharmaceuticals SA and Pharmathen International SA. Mr. Kadis has an MBA from Warwick Business School and an undergraduate degree from the National & Kapodistrian University of Athens.
Dimitris Kadis active positions
Companies | Position | Start |
---|---|---|
Pharmathen International SA
Pharmathen International SA Pharmaceuticals: MajorHealth Technology Pharmathen was founded in 1969 in Athens, as a private pharmaceutical company, and is focused on the development and marketing of pharmaceuticals, with a strong position in generics. With 3 state of the art research laboratories and 2 manufacturing units, Pharmathen is a completely vertically integrated company and its activities extend from the development of pharmaceutical products up to their distribution. The company's human resources works in the sectors of Research & Development (R&D), production and distribution of drugs to different countries worldwide. Now, Pharmathen's products are approved in all EU markets and distribution rights have been granted to the largest pharmaceutical companies in the world, particularly in Europe, the United States of America and Canada. | Director/Board Member | 2002-12-31 |
Pharmathen Pharmaceuticals SA
Pharmathen Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Pharmathen Pharmaceuticals SA develops and markets health care products. It manufactures cosmetics and pharmaceutical products and licenses out to the pharmaceutical companies in Europe, Canada, Australia, South Africa and the United States. The firm also distributes products in Africa, Asia, Latin America and the Middle East through a network of agents and distributors. The company was founded by Nicolas Katsos in 1969 and is headquartered in Pallini, Greece. | Director/Board Member | - |
Pharmathen SA
Pharmathen SA Pharmaceuticals: MajorHealth Technology Pharmathen SA develops, manufactures, and markets pharmaceuticals. Its products include a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. The company was founded in 1969 and is headquartered in Pallini, Greece. | Chief Executive Officer | 2019-06-30 |
Pharmathen Global BV
Pharmathen Global BV Miscellaneous Commercial ServicesCommercial Services Pharmathen Global BV is a Dutch research-centered pharmaceutical company that specializes in developing innovative generic products. The company is based in Amstelveen, Netherlands, and has subsidiaries in Greece. The company offers a complete package of integrated services, including finished products, know-how, and technological and regulatory support to partners worldwide. Pharmathen was founded in 1969, and Dimitris Kadis has been the CEO of the company since 2003. | Chief Executive Officer | 2002-12-31 |
Training of Dimitris Kadis
Warwick Business School | Masters Business Admin |
National & Kapodistrian University of Athens | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Pharmathen Pharmaceuticals SA
Pharmathen Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Pharmathen Pharmaceuticals SA develops and markets health care products. It manufactures cosmetics and pharmaceutical products and licenses out to the pharmaceutical companies in Europe, Canada, Australia, South Africa and the United States. The firm also distributes products in Africa, Asia, Latin America and the Middle East through a network of agents and distributors. The company was founded by Nicolas Katsos in 1969 and is headquartered in Pallini, Greece. | Health Technology |
Pharmathen SA
Pharmathen SA Pharmaceuticals: MajorHealth Technology Pharmathen SA develops, manufactures, and markets pharmaceuticals. Its products include a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. The company was founded in 1969 and is headquartered in Pallini, Greece. | Health Technology |
Pharmathen International SA
Pharmathen International SA Pharmaceuticals: MajorHealth Technology Pharmathen was founded in 1969 in Athens, as a private pharmaceutical company, and is focused on the development and marketing of pharmaceuticals, with a strong position in generics. With 3 state of the art research laboratories and 2 manufacturing units, Pharmathen is a completely vertically integrated company and its activities extend from the development of pharmaceutical products up to their distribution. The company's human resources works in the sectors of Research & Development (R&D), production and distribution of drugs to different countries worldwide. Now, Pharmathen's products are approved in all EU markets and distribution rights have been granted to the largest pharmaceutical companies in the world, particularly in Europe, the United States of America and Canada. | Health Technology |
Pharmathen Global BV
Pharmathen Global BV Miscellaneous Commercial ServicesCommercial Services Pharmathen Global BV is a Dutch research-centered pharmaceutical company that specializes in developing innovative generic products. The company is based in Amstelveen, Netherlands, and has subsidiaries in Greece. The company offers a complete package of integrated services, including finished products, know-how, and technological and regulatory support to partners worldwide. Pharmathen was founded in 1969, and Dimitris Kadis has been the CEO of the company since 2003. | Commercial Services |
- Stock Market
- Insiders
- Dimitris Kadis